Table 2 Changes in ophthalmic parameters after one-year atropine 0.01% treatment.

From: A multicenter Spanish study of atropine 0.01% in childhood myopia progression

Variable

Baseline visit

12 month visit

Mean change at 12 month

p-value*

SE (mean ± SD, D)

− 3.56 ± 1.12

− 4.00 ± 1.14

− 0.44 ± 0.41

0.0000

AL (mean ± SD, mm)

24.57 ± 0.79

24.84 ± 0.80

0.27 ± 0.20

0.0000

AC (mean ± SD, mm)

3.80 ± 0.32

3.83 ± 0.30

0.03 ± 0.25

0.0085

Pupil size (mean ± SD, mm)

5.60 ± 1.37

6.32 ± 1.11

0.74 ± 1.26

0.0000

Near VA (mean ± SD, logMAR)

0.00 ± 0.02

0.00 ± 0.01

0.00 ± 0.03

0.8539

Distance VA (mean ± SD, logMAR)

0.00 ± 0.03

− 0.01 ± 0.04

− 0.01 ± 0.05

0.3583

  1. *t Student and Wilcoxon test paired samples.
  2. SE Spherical Equivalent, SD standard deviation, D diopter, AL Axial length, AC Anterior chamber, VA Visual acuity, logMAR logarithm of minimum angle resolution.
Back to article page